Table of Contents
What is the stock’s outlook at Amwell?
Stock Price Predictions The median price target among the 12 analysts providing 12-month price projections for American Well Corp. Comparing the median estimate to the previous price of 2. Wall Street analysts who have provided 12-month price targets for Amcor in the previous three months. The high forecast is $11. The average price target represents a change of $8.In comparison to the current price of $11. The consensus analyst rating at ACM Research is Strong Buy. This is based on six Wall Street analysts’ ratings.
A public company, is Amwell?
Amwell declares the beginning of its initial public offering. The share price of Amwell’s stock opened at $25. IPO price of $18 and up 42% for the day. The company’s public debut could also act as a gauge for the telehealth market, which has seen growth as the COVID-19 pandemic has created a huge demand for remote care services.
Who is Amwell’s owner, exactly?
Boston, Massachusetts-based American Well Corporation, doing business as Amwell, is a telemedicine business that establishes safe video connections between patients and physicians. Roy Schoenberg, MD, MPH Since co-founding the company with his brother Ido Schoenberg, Amwell has developed into one of the largest telehealth eco-systems in the world, digitally connecting healthcare’s key stakeholders – payers, providers, and millions of patients – in an effective, contemporary healthcare experience.
How much money does Amwell have in total?
Over the course of 10 funding rounds, Amwell has raised $866M in total. On August 24, 2021, a Post-IPO Equity round of funding was raised for them. Brief Summary: Amwell, a provider of telehealth services, priced its initial public offering of approximately 41 million shares of Class A common stock at $18 per share, for gross proceeds of approximately $742 million.